logo
logo
LIVN stock ticker logo

LivaNova PLC

NASDAQ•LIVN
CEO: Mr. Alex Shvartsburg C.M.A.
セクター: Healthcare
業種: Medical - Devices
上場日: 2015-10-19
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
連絡先情報
20 Eastbourne Terrace, London, W2 6LG, United Kingdom
44-20-3325-0660
www.livanova.com
時価総額
$4.36B
PER (TTM)
40.5
40.4
配当利回り
--
52週高値
$80.74
52週安値
$41.02
52週レンジ
97%
順位51Top 71.3%
3.0
F-Score
改良版 Piotroski 分析
10年ファンダメンタル
弱い • 3 / 9 ポイント
スコアレンジ (0-9)
8-9: 価値が優れている
6-7: 基礎体質が強い
4-5: 全体的に堅調
0-3: パフォーマンスが弱い
データ期間: 2016-2025

深度リサーチ

財務データ
決算説明会
財務レポート
ニュース
損益計算書
バランスシート
キャッシュフロー計算書
財務比率
変化率
損益計算書
直近12ヶ月
データなし